Trevi Therapeutics, Inc. (TRVI) Social Stream



Trevi Therapeutics, Inc. (TRVI): $1.74

-0.16 (-8.42%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

TREVI THERAPEUTICS INC (TRVI) Price Targets From Analysts

Use the tables below to see what analysts covering TREVI THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-08-13 2 $10 $10 $10 $1.72 481.4%
2021-11-10 2 $10 $8 $9 $1.72 423.26%
2022-01-13 2 $8 $8 $8 $1.72 365.12%
2022-05-12 3 $8 $8 $8 $1.72 365.12%
2022-05-25 4 $10 $8 $8.666 $1.72 403.84%
2022-08-11 4 $10 $8 $9.333 $1.72 442.62%
2022-09-23 4 $12 $8 $10 $1.72 481.4%

The Trend in the Analyst Price Target


Over the past 20 months, TRVI's average price target has gone down $1.

TRVI reports an average of 437.35% for its upside potential over the past 45 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-11-11 2 8 8 8.000 1.18 577.97%
2022-01-13 2 8 8 8.000 0.74 981.08%
2022-05-25 4 10 8 8.666 2.20 293.91%
2022-07-01 4 10 8 9.333 2.92 219.62%
2022-08-11 4 10 8 9.333 4.27 118.57%

TRVI Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.25 3 1 0 0 0 4

The Trend in the Broker Recommendations


Over the past 62 days, TRVI's average broker recommendation rating improved by 0.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for TRVI as an investment opportunity.

  • TRVI has a higher average analyst price target than 74.78% of all US stocks.
  • In terms of how TREVI THERAPEUTICS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 814.87% of that group.
  • To contextualize these metrics, consider that out of all US stocks, TREVI THERAPEUTICS INC's number of analysts covering the stock is greater than 93.05% of them.
  • In terms of how TREVI THERAPEUTICS INC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than 29.73% of that group.

Stocks similar to TREVI THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are TMBR, TLSA, and SYN.

What is the outlook for TRVI? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5985 seconds.